![All lanes : Anti-RASSF8 antibody [3F7] (ab139326) at 1/2000 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY RASSF8 cDNALysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_4/21037_RASSF8-Primary-antibodies-ab139326-1.jpg)
All lanes : Anti-RASSF8 antibody [3F7] (ab139326) at 1/2000 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY RASSF8 cDNALysates/proteins at 5 µg per lane.

Immunohistochemical analysis of paraffin-embedded Human breast adenocarcinoma tissue labelling RASSF8 with ab139326 at 1/150 dilution.

Immunohistochemical analysis of paraffin-embedded Human ovary adenocarcinoma tissue labelling RASSF8 with ab139326 at 1/150 dilution.

Immunohistochemical analysis of paraffin-embedded Human pancreas tissue labelling RASSF8 with ab139326 at 1/150 dilution.

Immunohistochemical analysis of paraffin-embedded Human endometrium tissue labelling RASSF8 with ab139326 at 1/150 dilution.

Immunohistochemical analysis of paraffin-embedded Human bladder carcinoma tissue labelling RASSF8 with ab139326 at 1/150 dilution.

Immunofluorescent analysis of COS7 cells transiently transfected by pCMV6-ENTRY RASSF8, labelling RASSF8 with ab139326 at 1/100 dilution.